<DOC>
	<DOCNO>NCT01475890</DOCNO>
	<brief_summary>The purpose study evaluate safety efficacy vitamin D supplementation child , adolescent young adult Human Immunodeficiency Virus acquire immunodeficiency syndrome ( HIV/AIDS ) . The study 12-month randomize , double blind , placebo-controlled study vitamin D3 ( vit D ) supplementation use 7000IU/day base evidence Vit D Dose Finding Study-IRB 09-007332 .</brief_summary>
	<brief_title>Vitamin D Supplementation HIV</brief_title>
	<detailed_description>Optimal vitamin D ( vit D ) concentration metabolism essential normal immune function , growth , muscle , bone , inflammatory status child , adolescent adult HIV/AIDS . The impact vit D supplementation evaluate safety efficacy use clinically important outcome , overcome critical barrier use vit D supplementation research clinical care . Inexpensive easy administer , vit D supplementation may prove effective feasible treatment symptom prevention side effect people age live HIV/AIDS US around world . The study 12-month randomize , double blind , placebo-controlled study vitamin D3 ( vit D ) supplementation use 7000IU/day base evidence Vit D Dose Finding Study-IRB 09-007332 58 subject Perinatally Acquired ( PA ) Behaviorally Acquired ( BA ) HIV/AIDS assess long-term safety term serum calcium 25OHD concentration , efficacy term effect vit D supplementation 25OHD , cathelicidin , growth ( pre- peripubertal participant ) , body composition , bone , muscle , immune inflammatory status HIV/AIDS disease severity progression . Primary Hypotheses : H1 : Vit D supplementation safe result increase incidence elevate serum calcium ( age-specific range ) associate elevated serum 25OHD ( &gt; 160 ng/mL ) treat subject compare subject receive placebo . H2 : Vit D supplementation significantly associate increase 25D cathelicidin treat subject compare subject receive placebo .</detailed_description>
	<mesh_term>HIV Infections</mesh_term>
	<mesh_term>Vitamins</mesh_term>
	<mesh_term>Vitamin D</mesh_term>
	<mesh_term>Ergocalciferols</mesh_term>
	<mesh_term>Cholecalciferol</mesh_term>
	<criteria>1 . HIV seropositive diagnose standard technique 2 . Age PA Group : 5.0 24.9 3 . Age BA Group : 15.0 24.9 4 . In usual state good health ( hospitalization , emergency room unscheduled acute illness visit 2 week prior enrollment ) 5 . Subject and/or family commitment 12month study 1 . Other chronic health condition may affect growth , dietary intake , and/or nutritional status 2 . Pregnancy 3 . Participation another HIV intervention study impact 25D serum concentration 4 . Use vit D3 supplementation purpose treat vit D deficiency 5 . Use vit D3 supplementation part prescribe treatment plan vit D deficiency ( subject willing discontinue supplementation become eligible minimum 2 month washout period ) 6 . NonEnglish Speaking</criteria>
	<gender>All</gender>
	<minimum_age>5 Years</minimum_age>
	<maximum_age>24 Years</maximum_age>
	<verification_date>March 2017</verification_date>
	<keyword>HIV/AIDS</keyword>
	<keyword>Nutrition</keyword>
</DOC>